Should the United States Government Repeal Restrictions on Buprenorphine/Naloxone Treatment?
about
Fifty Years in the Development of a Glutaminergic-Dopaminergic Optimization Complex (KB220) to Balance Brain Reward Circuitry in Reward Deficiency Syndrome: A Pictorial"Pro-dopamine regulation (KB220Z™)" as a long-term therapeutic modality to overcome reduced resting state dopamine tone in opiate/opioid epidemic in America.Why aren't physicians prescribing more buprenorphine?Hypothesizing that a Pro-Dopaminergic Regulator (KB220z™ Liquid Variant) can Induce "Dopamine Homeostasis" and Provide Adjunctive Detoxification Benefits in Opiate/Opioid Dependence.The relationship between treatment accessibility and preference amongst out-of-treatment individuals who engage in non-medical prescription opioid use.A Systematic, Intensive Statistical Investigation of Data from the Comprehensive Analysis of Reported Drugs (CARD) for Compliance and Illicit Opioid Abstinence in Substance Addiction Treatment with Buprenorphine/naloxone.
P2860
Should the United States Government Repeal Restrictions on Buprenorphine/Naloxone Treatment?
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Should the United States Gover ...... renorphine/Naloxone Treatment?
@en
Should the United States Gover ...... renorphine/Naloxone Treatment?
@nl
type
label
Should the United States Gover ...... renorphine/Naloxone Treatment?
@en
Should the United States Gover ...... renorphine/Naloxone Treatment?
@nl
prefLabel
Should the United States Gover ...... renorphine/Naloxone Treatment?
@en
Should the United States Gover ...... renorphine/Naloxone Treatment?
@nl
P2093
P2860
P1476
Should the United States Gover ...... renorphine/Naloxone Treatment?
@en
P2093
H Westley Clark
Kenneth Blum
Kristina Dushaj
Rajendra D Badgaiyan
P2860
P304
P356
10.1080/10826084.2016.1200097
P577
2016-07-27T00:00:00Z